Skip to main content

Semaglutide – 5 mg Vial

a GLP-1 peptide known for supporting appetite control, stable blood sugar, and effective weight-management results.

Semaglutide – 5 mg Vial

For laboratory research and development purposes only

*Semaglutide is the active ingredient in Ozempic


Overview

Semaglutide is a synthetic peptide that acts on the GLP-1 receptor, a key pathway involved in appetite regulation and glucose metabolism. In research settings, it is used to study mechanisms related to metabolic function, energy intake, and insulin signaling.

This product contains 5 mg of lyophilized Semaglutide, intended solely for qualified laboratories and research professionals.


How It Works (Research Summary)

Semaglutide is a long-acting GLP-1 receptor agonist with structural similarity to human GLP-1. Research has shown that activating the GLP-1 pathway can influence:

  • Appetite and satiety signaling in the central nervous system

  • Gastric emptying rates, affecting nutrient absorption and hunger cues

  • Glucose regulation, including insulin secretion and glucagon suppression

  • Metabolic markers relevant to weight-related studies

Its extended activity—lasting roughly one week—is attributed to strong albumin binding and resistance to enzymatic breakdown.

These characteristics make Semaglutide a widely studied molecule in metabolic and weight-related research models.


Observed Research Outcomes

Potential Research Applications

  • Studying the role of GLP-1 receptors in appetite control

  • Examining glucose-dependent insulin pathways

  • Researching mechanisms behind weight-related metabolic changes

  • Modeling long-acting peptide therapeutics and pharmacokinetics

Commonly Reported Observations in Studies

  • Reduced caloric intake

  • Gastrointestinal responses (nausea, bloating, altered bowel patterns)

  • Changes in appetite or satiety cues

  • Injection-site irritation

  • Improved glucose-regulation markers in metabolic models

Serious Observations Reported in Literature

  • Pancreatitis or gallbladder complications in rare study conditions

  • Kidney strain in dehydration-prone models

  • Thyroid C-cell tumor findings in rodent studies (uncertain relevance to humans)

These findings come from published clinical and preclinical data and may not occur outside controlled research environments.


Product Details

  • Peptide: Semaglutide

  • Quantity: 5 mg vial

  • Form: Lyophilized powder

  • Purity: ≥ 98% (HPLC verified)

  • Use: Laboratory and research applications only

  • Storage: Refrigerate; protect from heat and light



Disclaimer:

All peptide products sold on this website are for research, laboratory, and educational purposes only. They are not approved by the FDA or Health Canada, are not intended for human consumption, and should not be used for medical, cosmetic, or therapeutic purposes unless specifically prescribed by a licensed healthcare professional.

The information provided on this site is for informational and educational purposes only and does not constitute medical advice. Product descriptions, protocols, or references are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new protocol, supplement, or treatment.

By purchasing from this website, you acknowledge and agree to use these products responsibly and in accordance with all applicable laws and guidelines.

Did this answer your question?